Research News and Research

RSS

Safinamide improves responder rates in fluctuating Parkinson's patients in Phase III study

Newron Pharmaceuticals S.p.A. ("Newron"), a research and development company focused on novel CNS and pain therapies, and its partner Zambon S.p.A., a pharmaceutical company strongly committed to the respiratory, primary care and CNS therapeutic areas, presented results from SETTLE Phase III study with safinamide at the 17th International Congress of Parkinson's disease and Movement Disorders, taking place from June 16 to 20, 2013, at the Sydney Convention and Exhibition Centre, Sydney, Australia.

19 Jun 2013

High Court: Feds can sue pharmaceutical companies over deals to delay generic drug sales

The Supreme Court ruled Monday that the Federal Trade Commission can challenge name brand drug makers for potential antitrust violations.

19 Jun 2013

Diet, lifestyle and environment attribute to the cause of majority of cancer cases

Diet, lifestyle and the environment are all factors attributed to the cause of the majority of cancer cases and it has been estimated that up to half of all cancers may be preventable according to research by a University of Leicester scientist.

19 Jun 2013

Study says public health strategies can be applied to prevent bullying and suicide

Recent studies linking bullying and depression, coupled with extensive media coverage of bullying-related suicide among young people, led the Centers for Disease Control and Prevention (CDC) to assemble an expert panel to focus on these issues. This panel synthesized the latest research about the complex relationship between youth involvement in bullying and suicide-related behaviors.

19 Jun 2013

Ico Therapeutics completes Phase 2 iDEAL study for treatment of diabetic macular edema

iCo Therapeutics Inc. announced today that it has completed enrollment of its Phase 2 iDEAL study evaluating the efficacy and safety after repeated injections of iCo-007 in patients with Diabetic Macular Edema (DME). The study has shown a good safety profile with no drug-related serious adverse events to date.

19 Jun 2013

Journal of Bone and Joint Surgery reveals important trends and changes in orthopaedic practice

Data from the recent release from The Journal of Bone and Joint Surgery, The Third Annual Role of the Orthopaedic Surgeon Study 2013, reveals important trends in the ways that orthopaedic practice is changing in the face of significant increases in hospital-owned practices, cost pressures, and regulations.

19 Jun 2013

New blood test finds cancer-related microRNA in blood before tumor development

A new blood test developed in the Gastrointestinal Cancer Research Lab at Baylor Research Institute is showing very promising results for finding cancer-related microRNA in the blood before a tumor develops in the colon.

19 Jun 2013

World-renowned leader in care and treatment of burn injury awarded highest honor from Loyola University

Richard L. Gamelli, MD, FACS, a world-renowned leader in the care and treatment of burn injury, is being awarded Loyola University Chicago Stritch School of Medicine's highest honor.

19 Jun 2013

New framework to improve safety and effectiveness of surgical procedures, implantable devices

An international team of investigators co-led by Weill Cornell Medical College is offering a new framework for evidence-based surgery and device research, similar to the kind of risk and benefit analysis used in evidence-based medicine.

19 Jun 2013

Patient enrollment and trial duration heavily impact the total cost of Phase 1 oncology trial

Both the number of patients and trial duration heavily impact a Phase 1 oncology trial's total cost. The underlying force driving most costs is patient enrollment. As the time to reach full enrollment increases, the trial lasts longer and the cost of maintaining and staffing clinical sites rises.

19 Jun 2013

Montana scientist receives ICAAC Young Investigator Award for research on memory responses to infection

Joshua Obar, Ph.D., Department of Immunology and Infectious Diseases, Montana State University-Bozeman, has been honored with a 2013 ICAAC Young Investigator Award for his research on factors affecting the regulation of immunological memory responses to infection.

19 Jun 2013

Study shows state health care price websites need to be improved

"With rising health care costs and 30 percent of privately insured adults enrolled in high-deductible health care plans, calls for greater health care price transparency are increasing. In response, health plans, consumer groups, and state governments are increasingly reporting health care prices.

19 Jun 2013

Signaling pathway correlates with EGFR status and poor survival in breast cancer patients

Researchers have discovered and mapped the signaling network between two previously unconnected proteins, exposing a link that, if broken, could cut off cancer cell growth at its starting point.

19 Jun 2013

OHSU analysis finds previous studies have overstated effectiveness of bone growth product used in spinal surgeries

An analysis by the Evidence-based Practice Center at Oregon Health & Science University has found that previously published clinical trial studies about a controversial bone growth product used in spinal surgeries overstated the product's effectiveness.

19 Jun 2013

New breakthrough in chemical nanoengineering may help develop light-regulated therapeutic molecules

The scientific cooperation between chemists, biotechnologists and physicists from various Catalan institutes, headed by Pau Gorostiza, from the Institute for Bioengineering of Catalonia (IBEC), and Ernest Giralt, from the Institute for Research in Biomedicine (IRB Barcelona), has led to a breakthrough that will favor the development of light-regulated therapeutic molecules.

19 Jun 2013

NIH awards $12.7M to research groups to explore new treatments for patients in eight disease areas

The National Institutes of Health has awarded $12.7 million to match nine academic research groups with a selection of pharmaceutical industry compounds to explore new treatments for patients in eight disease areas, including Alzheimer's disease, Duchenne muscular dystrophy and schizophrenia.

19 Jun 2013

First Edition: June 19, 2013

Today's headlines include reports the development of the health law's online marketplaces is falling behind schedule.

19 Jun 2013

Viewpoints: Controlling costs; Health law's guarantee of coverage; ACO liability

In the impassioned debates over healthcare, one fact is often lost - Americans pay more but get less for their health care than residents of other high-income countries. I believe we can change that. We can improve the quality of care and reduce our expenses, saving a trillion dollars or more a year, by making our health care system more efficient (William A. Haseltine, 6/17).

19 Jun 2013

Combination of two proteins released after head injury might be best way to diagnose MTBI

Scientists are scrambling to gather data for the FDA to support the need for a blood test to diagnose brain injury in the United States. The University of Rochester Medical Center just added significant evidence by reporting in the Journal of Neurotrauma that it might be clinically useful to measure two brain biomarkers instead of one.

19 Jun 2013

Researchers discover a rational source of pain in skin of patients with fibromyalgia

Fibromyalgia, a painful condition affecting approximately 10 million people in the U.S., is not imaginary after all, as some doctors have believed. A discovery, published this month in PAIN MEDICINE (the journal of the American Academy of Pain Medicine), clearly now demonstrates that fibromyalgia may have a rational biological basis located in the skin.

19 Jun 2013

Research News and Research

Safinamide improves responder rates in fluctuating Parkinson's patients in Phase III study

High Court: Feds can sue pharmaceutical companies over deals to delay generic drug sales

Diet, lifestyle and environment attribute to the cause of majority of cancer cases

Study says public health strategies can be applied to prevent bullying and suicide

Ico Therapeutics completes Phase 2 iDEAL study for treatment of diabetic macular edema

Journal of Bone and Joint Surgery reveals important trends and changes in orthopaedic practice

New blood test finds cancer-related microRNA in blood before tumor development

World-renowned leader in care and treatment of burn injury awarded highest honor from Loyola University

New framework to improve safety and effectiveness of surgical procedures, implantable devices

Patient enrollment and trial duration heavily impact the total cost of Phase 1 oncology trial

Montana scientist receives ICAAC Young Investigator Award for research on memory responses to infection

Study shows state health care price websites need to be improved

Signaling pathway correlates with EGFR status and poor survival in breast cancer patients

OHSU analysis finds previous studies have overstated effectiveness of bone growth product used in spinal surgeries

New breakthrough in chemical nanoengineering may help develop light-regulated therapeutic molecules

NIH awards $12.7M to research groups to explore new treatments for patients in eight disease areas

First Edition: June 19, 2013

Viewpoints: Controlling costs; Health law's guarantee of coverage; ACO liability

Combination of two proteins released after head injury might be best way to diagnose MTBI

Researchers discover a rational source of pain in skin of patients with fibromyalgia

eBook: Advancing neurodegenerative research with iPSC-derived microglia models eBook

Latest eBooks

Editorial Focus eBook - Proteomics (2nd Edition)

Industry Focus eBook - Life Science Microscopy (2nd Edition)

BFEB: Advances in microplate-based assays and analysis

Biologics stability screening toolkit: Three practical workflows for accelerating formulation development

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery